Retrophin Inc (RTRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
24.25 -0.11 (-0.45%) 11/18/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 24.25 unch (unch) -
for Wed, Nov 18th, 2020
Results
download Want to compare other data? Select Fields| Symbol | RTRX | NEO | ETNB | ||
| Company | Retrophin Inc | Neogenomics Inc | 89Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.57 | 9.80 | 8.46 | ||
| High | 24.74 | 10.17 | 8.81 | ||
| Low | 24.04 | 9.75 | 8.37 | ||
| Last | 24.25 | 10.00 | 8.79 | ||
| Change | -0.11 | +0.18 | +0.32 | ||
| % Change | -0.45% | +1.83% | +3.78% | ||
| Volume | 378,900 | 434,516 | 565,400 | ||
| 20-Day Average Volume | 335,225 | 1,603,974 | 1,532,979 | ||
| Previous Close | 24.36 | 9.83 | 8.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.07 | 10.48 | 9.10 | ||
| 20-Day Raw Stochastic | 86.95% | 24.31% | 41.53% | ||
| 20-Day Relative Strength | 67.64% | 40.61% | 48.59% | ||
| Weighted Alpha | +75.80 | -39.86 | -25.48 | ||
| Today's Opinion | 100% Buy | 100% Sell | 56% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.04% since 11/11/20 | +10.40% since 03/10/25 | +21.96% since 03/10/25 | ||
| Low | 23.33 on 11/13/20 | 9.00 on 03/11/25 | 6.88 on 03/11/25 | ||
| High | 24.74 on 11/18/20 | 10.95 on 03/11/25 | 8.77 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | +10.78% since 10/16/20 | -30.44% since 02/14/25 | -17.50% since 02/14/25 | ||
| Low | 19.52 on 11/02/20 | 8.98 on 03/04/25 | 6.88 on 03/11/25 | ||
| High | 24.96 on 11/11/20 | 13.30 on 02/18/25 | 11.31 on 02/19/25 | ||
| 3-Month | |||||
| %Chg | +31.58% since 08/18/20 | -42.85% since 12/17/24 | +9.27% since 12/17/24 | ||
| Low | 17.22 on 09/24/20 | 8.98 on 03/04/25 | 5.99 on 01/16/25 | ||
| High | 24.96 on 11/11/20 | 19.11 on 01/08/25 | 11.84 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | +47.33% since 05/18/20 | -38.43% since 09/17/24 | +4.43% since 09/17/24 | ||
| Low | 14.50 on 06/11/20 | 8.98 on 03/04/25 | 5.99 on 01/16/25 | ||
| High | 24.96 on 11/11/20 | 19.11 on 01/08/25 | 11.84 on 02/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,238,011 | 1,262,129 | 1,236,485 | ||
| Shares Outstanding, K | 51,052 | 128,461 | 145,984 | ||
| Annual Sales | 175,340,000 | 660,570,000 | 0 | ||
| Annual Net Income | -146,430,000 | -78,730,000 | -367,080,000 | ||
| Last Quarter Sales | 51,140,000 | 172,000,000 | 0 | ||
| Last Quarter Net Income | -22,550,000 | -15,320,000 | -118,350,000 | ||
| 60-Month Beta | 0.71 | 1.28 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/24/20 | 0.04 on 02/18/25 | -1.02 on 02/27/25 | ||
| Latest Earnings Date | 11/05/20 | 04/29/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||